User Name Password

back to homepage

London Capital (LCG.L) - recent results confirm our forecasts
LCG.L
Update by Andy Hartwill , Aug 12, 2008 (login for full report)
Click for previous reports on this company
Questions? Contact our analyst

Key Points:

  • Overall. Unsurprisingly it is the spread betting business, Capital Spreads, that is making all of the running – both in absolute size and in growth rates. Forex effectively “flatlined” in the first half but that reflected the removal of two major clients.

  • Spread betting. Capital Spreads added over 6,700 new clients during the period bringing the total number of “live” accounts to 25,853 (from 13,180). Client acquisition costs were largely unchanged at around £95 per live client. The average number of daily trades (per 100 live accounts) rose to 64 (from 53) although the average value per trade dropped to £4.3 (from £6.0) and the proportion of “active” clients dropped to 37.4% from 43.9%.

  • Forex. Capital Forex (15% of group gross revenues (GGR)) added 120 new institutional clients during the first half and saw client funds rise to £22.4m (from £18.4m in 1h ’07).

  • Institutional broking. Capital Derivatives (less than 6% of GGR) saw modest growth but that was achieved despite a slowdown in the second quarter. Trading volumes rose by almost 19% to 1.6m lots.

  • Effect on forecasts. The interim results were broadly speaking in line with our model although overall COGS was at almost 21% marginally higher than the 18.5% we have estimated for the full year. The difference amounts to some £0.6m at the gross profit line in the current full year. Given London Capital’s track record we are content for now to leave our COGS and thus overall estimates unchanged.

Free registration required for full report

SIGN UP NOW FOR OBJECTIVE'S STOCK RESEARCH - IT'S FREE!

Objective, Independent, Experienced.
Research you can trust!

Yes! Subscribe me for the latest stock research from Objective.
Email address
My Password
My information:
First Name
Family Name
Title:
Job title:
Job function:
Industry:
I am a:
 
To receive occasional printed reports complete your mailing address:
 
Company Name (if any)
Address
 
 
City
Postcode/Zip
Country

Please Read Objective's Terms of Use.


Balkan Resources (Private) - exploring the Perlati copper deposit in Albania
Oct 09, 2009 | Previous Reports

Scancell Holdings (SCLP.PLUS) - differentiated technology and a focused plan offer ingredients for success
Sep 08, 2009 | Previous Reports

Sofame Technologies (SDW.V) - ambitious, but high risk growth strategy
Aug 24, 2009 | Previous Reports

Soho Resources (SOH.V) - substantial upgrade to total resource
Aug 19, 2009 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

e-Therapeutics (ETX.L) - ‘success-predictive’ drug discovery may be the key to new treatment horizons
Nov 18, 2008 | Previous Reports

Great Western Minerals (GWG.V) - pressing ahead with mine-to-market strategy
Nov 07, 2008 | Previous Reports

LiDCO (LID.L) - half year results show early signs of being on track
Oct 30, 2008 | Previous Reports

OCCASIONAL PAPERS

Albania - revisting old frontiers
October, 2008

The rise of independent research (IR Magazine)
March, 2006

Presentation to 2005 AIM Conference
Sept 26, 2005

The Role of Sponsored Research
June 22, 2005

Objective's Corporate Brochure
July 01, 2004

Objective Capital's Contact Information
Partnership, sales and product inquiries: marketing@objectivecapital.co.uk
Media services and conference requests: PR@objectivecapital.co.uk
Subscription and customer service issues: service@objectivecapital.co.uk
Comments or opinions on our analysis: analysis@objectivecapital.co.uk

11-12 Tokenhouse Yard, London EC2R 7AS, United Kingdom
ph +44-(0)870-080 2965 fax +44-(0)870-116 0839

About Us | Contact Us
Latest Analysis | Register Free | Archives
 
Copyright 2004 Objective Capital. All rights reserved.
Terms of Use | Privacy Policy | Disclaimer